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Abstract
The ultrastructural changes in diabetic and idiopathic gastroparesis are not well studied and it is not known whether there are different
defects in the two disorders. As part of the Gastroparesis Clinical Research Consortium, full thickness gastric body biopsies from 20
diabetic and 20 idiopathic gastroparetics were studied by light microscopy. Abnormalities were found in many (83%) but not all patients.
Among the common defects were loss of interstitial cells of Cajal (ICC) and neural abnormalities. No distinguishing features were seen
between diabetic and idiopathic gastroparesis. Our aim was to provide a detailed description of the ultrastructural abnormalities, com-
pare findings between diabetic and idiopathic gastroparesis and determine if patients with apparently normal immunohistological fea-
tures have ultrastructural abnormalities. Tissues from 40 gastroparetic patients and 24 age- and sex-matched controls were examined
by transmission electron microscopy (TEM). Interstitial cells of Cajal showing changes suggestive of injury, large and empty nerve end-
ings, presence of lipofuscin and lamellar bodies in the smooth muscle cells were found in all patients. However, the ultrastructural
changes in ICC and nerves differed between diabetic and idiopathic gastroparesis and were more severe in idiopathic gastroparesis. A
thickened basal lamina around smooth muscle cells and nerves was characteristic of diabetic gastroparesis whereas idiopathic gastro-
paretics had fibrosis, especially around the nerves. In conclusion, in all the patients TEM showed abnormalities in ICC, nerves and
smooth muscle consistent with the delay in gastric emptying. The significant differences found between diabetic and idiopathic gastro-
paresis offers insight into pathophysiology as well as into potential targeted therapies.
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Introduction
Gastroparesis is a disorder characterized by chronic delay in gas-
tric emptying in the absence of obstruction. Gastroparesis is most
commonly associated with diabetes (both type 1 and type 2) or 
is of unknown cause (idiopathic) [1, 2]. Idiopathic and diabetic
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gastroparesis are assumed to have very different pathophysiology
but presently there are no known cellular abnormalities that can
separate the two disorders.
Most of our understanding of the cellular basis for gastropare-
sis has come from animal studies focused on diabetic gastropare-
sis [3—10] with limited human studies [11—21]. The lack of
understanding of the cellular aetiology of gastroparesis is a signif-
icant limitation to developing targeted therapy. In response to the
limited information known about gastroparesis and the limited
therapies currently available, the National Institutes of Health
established a Gastroparesis Clinical Research Consortium
(GpCRC). As part of this consortium 40 full thickness gastric body
biopsies (20 diabetic, 20 idiopathic) were collected from patients
with diabetic and idiopathic gastroparesis and 20 site-, age- and
sex-matched controls and then studied by immunohistochemistry
[22]. The main finding of that study was that 83% of these patients
had a cellular abnormality. The most common findings were loss
of interstitial cells of Cajal (ICC), changes in enteric nerves and an
immune cell infiltrate. None of the cellular abnormalities differen-
tiated diabetic and idiopathic gastroparesis. Also in 17% of gastro-
paretics, no abnormality was found by light microscopy. In the
same study, TEM examination was conducted on a limited number
of the patients chosen because of their ICC and nerve abnormali-
ties which confirmed the immunohistochemical findings [22].
The aim of the present study was to use TEM to provide a
detailed description of the ultrastructural abnormalities in patients
with diabetic and idiopathic gastroparesis, determine if there are
distinguishing features at the ultrastructural level between diabetic
and idiopathic gastroparesis and determine if patients with appar-
ently normal immunohistological features have ultrastructural
abnormalities.
Materials and methods
We used tissue from 60 full-thickness gastric biopsies, 58 of which had
been previously studied by immunohistochemistry [22]. In the previous
study, we did not have tissue processed for electron microscopy on two
patients and therefore two new patients for whom we had both immuno-
histochemistry and electron microscopy processed tissue were added.
Tissue was collected from the anterior aspect of the stomach, midway
between the greater and lesser curvatures where the gastroepiploic vessels
meet. The anatomy of individual stomachs varies but, in general, the region
where the gastroepiploic arteries meet is about 9 cm proximal to the
pylorus. Tissues were obtained from 20 diabetic and 20 idiopathic gastro-
paretic patients undergoing surgery for placement of a gastric electrical
stimulator and from 20 age- and sex-matched patients undergoing gastric
bypass surgery for obesity (Table 1) following IRB approved protocols. A
technician in the operating room ensured that ischaemic time was mini-
mized and the tissue properly cut, stored and transported. The control tis-
sue was selected from patients that did not have diabetes, did not report
gastrointestinal symptoms and had a screening H and E slide read as 
normal. To determine if the 20 controls used were different from non-obese
controls, thus causing any significant histological changes, we prospec-
tively collected full thickness gastric biopsy specimens from 4 non-obese,
non-gastroparetic subjects [gastro-esophageal junction cancer with no
previous weight loss (5 lbs), and no previous chemotherapy or radiation
therapy] and compared histological changes with the above control group.
For electron microscopy, four strips for each patient, 1 mm  10 mm
long and containing the muscularis propria plus a small portion of the tunica
submucosa, were immediately cut after the full thickness biopsy was
obtained and fixed for 6 hrs in a solution of 2% glutaraldehyde 0.1M in
cacodylate buffer, pH 7.4. After four rinses in the cacodylate-buffered solu-
tion containing 0.22M sucrose, the strips were post-fixed for 1 hr in 1%
OsO4 in 0.1M phosphate buffer. After a rinse for 30 min. in ddH2O, the strips
were en bloc stained in 2% uranyl acetate for 30 min. at 55C and rinsed
again in ddH2O for 10 min. Dehydration was carried out in graded ethanol
and the strips then embedded in Spurr using flat moulds to obtain full-thick-
ness sections with the circular muscle cut in cross-section. Semi-thin sec-
tions, obtained with an LKB NOVA ultramicrotome (Stockholm, Sweden),
were stained with a solution of toluidine blue in 0.1M borate buffer and then
observed under a light microscope. Circular muscle and myenteric plexus
rich areas away from the strips’ edges with no apparent signs of mal- fixation
or processing artefacts were selected. Ultra-thin sections of these selected
areas were obtained with the LKB NOVA ultramicrotome using a diamond
knife and stained with a saturated solution of uranyl acetate in methanol
(50:50) per 12 min. at 45C, followed by an aqueous solution of concentrated
bismuth subnitrate per 10 min. at room temperature. At least 10–20 ultra-
thin sections from all four strips of each patient were examined under a JEOL
1010 electron microscope (JEOL Ltd., Tokyo, Japan) and photographed.
Results
The ultra-structural features of age- and sex-matched patients
undergoing gastric bypass surgery used as controls were similar
to those seen in the non-obese patients undergoing gastric sur-
gery for carcinoma and those reported in literature as normal fea-
tures [23, 24] (Fig. 1A–E). Conversely, all of the gastroparetic
patients had ultrastructural abnormalities, both those with at least
one immunohistochemical abnormality and those with no appar-
ent abnormalities on immunohistochemistry (Table 1).
Diabetic gastroparesis
As compared to controls, 17 of the 20 (85%) diabetic gastroparet-
ics had ultrastructural changes in ICC morphology. Morphological
abnormalities consisted of the presence of several intracytoplasmic
vacuoles (Fig. 2A), mitochondria with a clear matrix (Fig. 2B) and
an extended rough endoplasmic reticulum (Fig. 2C). All of these
abnormalities were not always all present in the same cell and nor-
mal ICC were also present in some of these patients, together with
the altered ones. Apoptotic features (compact  chromatin filling the
entire nucleus or as dark clumps close to remnants of the nuclear
envelope, cytoplasm either completely empty or containing few
swollen mitochondria, increased  lysosomes) were also observed in
all of the patients with ultrastructural changes (Fig. 3A). In contrast
to controls, for all diabetic gastroparetics with ultrastructural
changes, none of the ICC visualized were in contact with nerve
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Table 1 Age, sex of patients and immunohistochemical abnormalities 
Controls Diabetic gastroparesis Idiopathic gastroparesis
Age Sex Age Sex IHC abnormalities Age Sex IHC abnormalities
1 25 F 19 F ICC, nerves 19 F Nerves, fibrosis
2 26 M 20 F Nerves, immune cells 20 F Immune cells
3 28 M 25 M Muscle, fibrosis, immune cells 20 F None
4 33 M 32 F None 26 M ICC, nerves
5 34 F 34 M ICC, nerves, immune cells 27 F ICC, nerves, muscle
6 36 F 37 M Immune cells 29 F None
7 36 M 40 F Nerves, immune cells 30 F Muscle, nerves, immune cells, ICC
8 37 F 41 F None 31 F ICC, nerves
9 37 F 42 F Nerves, immune cells 33 F ICC, nerves, immune cells
10 38 M 46 F ICC, nerves 33 F None
11 40 F 48 M None 35 F Muscle, nerves, immune cells
12 43 F 22 F ICC, nerves, fibrosis 37 F ICC, nerves, immune cells
13 44 F 50 M ICC, nerves, immune cells 40 F Nerves, fibrosis
14 48 F 55 F ICC, nerves, immune cells 45 F Nerves, fibrosis
15 50 F 56 F ICC, nerves 46 M Muscle, nerves, immune cells
16 51 F 58 M Nerves 50 F ICC, nerves, immune cells
17 58 F 37 F None 52 M ICC, nerves
18 64 F 60 F ICC, nerves, muscle, immune cells 55 M ICC, nerves
19 64 M 66 F ICC 64 M ICC,
20 70 F 68 M ICC, muscle 75 F Muscle, nerves, immune cells
Fig. 1 Interstitial cells of Cajal, smooth
muscle cells and nerves in control patients.
(A) An Interstitial cells of Cajal (ICC) with
normal features: several caveolae are
located along the cell contour, bundles of
intermediate filaments and cisternae of
smooth and rough endoplasmic reticulum
are present in the cytoplasm. Bar  1.6 m.
(B) Two ICC (ICC1 and ICC2) whose thin
cell projections are in contact to each other
(square). The ICC1 is also in contact (two
asterisks: a desmosome-like junction; one
asterisk: a gap junction) with a smooth
muscle cell (SMC). Bar  1 m. (C) A
close contact between one nerve ending
(N) and an ICC (ICC). Nearby a smooth
muscle cell (SMC). Bar  1 m. (D) A gap
junction (asterisk) between two smooth
muscle cells. Bar  0.45 m. (E) Six nerve
endings (N, arrows) most of which are free
in the stroma, i.e. have not a glial sheath.
(A, C and D) are from obese controls, (B
and E) from patients operated for gastric
carcinoma. Bar  1 m.
ICC: interstitial cells of Cajal.
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 endings and rarely had cell-to-cell contact with smooth muscle
cells (Fig. 2A) and other ICC. Amounts of flocculent and filamen-
tous material, similar to a basal lamina, were occasionally found
around ICC (Fig. 2B and C). Both, intramuscular ICC and ICC in the
myenteric plexus region had similar ultrastructural changes.
In all of the patients, the majority of the smooth muscle cells
appeared normal and only a few (no more than 2–3 cells/section)
showed morphological alterations, such as vacuoles, abundant
lipofuscin bodies (Fig. 3B), swollen mitochondria (Fig. 4A), lamel-
lar bodies, disordered arrangement of myofilaments, with the
myofilaments no more parallel to each other or to the major axis
of the cell (Fig. 4B). Gap junctions (Fig. 4C) were present in both
Fig. 2 Interstitial cells of Cajal abnormalities in diabetic gastroparesis. (A)
An interstitial cell of Cajal (ICC) with normal features, apart from a small
intracytoplasmatic vacuole (asterisk, patient #4). The arrow indicates a gap
junction between two smooth muscle cells (SMC). Bar  0.6 m. (B) An
ICC with mitochondria with clear matrix and short cristae in contact
(arrow) with a smooth muscle cell (SMC, patient #14). The ICC nucleus has
an irregular contour so the cell appears as having two nuclei. Bar  0.8 m.
(C) Two ICC with an extended rough endoplasmic reticulum (rer) encased
in a stroma rich in collagen fibrils (patient #14). In (B and C), the ICC have
thick amounts of basal lamina-like material (asterisks). Bar  1 m.
Fig. 4 Smooth muscle cells changes in diabetic gastroparesis. (A) A smooth
muscle cell (SMC) with clustered and swollen mitochondria (m) and a
patchily thickened basal lamina (asterisks, patient #10). Bar  0.8 m. (B)
A smooth muscle cell encased in a stroma rich in collagen fibrils (f) and with
lamellar bodies (arrow) and chaotically arranged myofilaments (asterisks,
patient #2). Bar  0.5 m. (C) Detail of a gap junction (asterisk, patient #1)
between two smooth muscle cells with normal features. Bar  0.4 m.
Fig. 3 Altered interstitial cells of Cajal (ICC) 
and smooth muscle in diabetic gastroparesis.
(A) A presumed ICC with apoptotic features:
clumps of compacted chromatin filling the
entire nucleus, a cytoplasm containing swollen
mitochondria and lysosomes. SMC: smooth
muscle cell (patient #4). Bar  0.8 m. (B) A
smooth muscle cell with a large lipofuscin
body (Ly) near the nucleus. Basal lamina is
patchily thickened and the stroma rich in colla-
gen fibrils (patient #11). Bar  0.8 m.
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normal and abnormal cells, although the connective tissue was
filled with thin collagen fibrils that distanced the smooth muscle
cells form each other (Figs 4B and 5A). Except for one patient 
(# 10), the basal lamina was patchily (Fig. 5B) or continuously
(Fig. 5A and C) markedly thickened (up to 0.6 m versus the 
0.06 m of controls) in all diabetic gastroparetics.
In most of the subjects (except #6, that had only a few altered
nerve endings), in each section, the nerve bundles contained sev-
eral altered nerve endings. Abnormal nerve endings were large
and either empty (Fig. 6A) or, especially in the patient 10, filled
with filaments and microtubules (Fig. 6B). In the latter patient, the
basal lamina had a normal thickness and elastic fibres attached the
nerve endings to the smooth muscle cells (Fig. 6B) which was a
finding in patients with idiopathic gastroparesis (see below) but
not in controls. All other patients had a thick basal lamina and/or
a thick sheath made by collagen fibrils (Figs 5B and 6C) around
nerve fibres that appeared to be characteristic for diabetic gastro-
paresis. Free nerve endings (Fig. 6D), although few, were present
and some of them, as in controls, were in close contact with
smooth muscle cells.
The connective stroma always had an abnormal appearance. In
particular, in many of the patients, even in the youngest ones,
there was a large quantity of collagen fibrils not assembled in bun-
dles, and the basal lamina was always either patchily or continu-
ously thickened. Mast cells were frequently seen.
Idiopathic gastroparesis
There was a marked dropout of ICC in all idiopathic gastroparetics.
Ultrastructural damage to ICC was more marked than in  diabetic
gastroparesis. Except for patients 4, 14 and 15 that had few (no
more than 2–3 cells in 10 sections examined) patchily  distributed
normal residual ICC (Fig. 7A) all others had abnormal ICC features.
The remaining cells were often hard to recognize as ICC as they had
few mitochondria which was in contrast to normal ICC and all had
a clear matrix and few cristae, many lamellar  bodies and extremely
Fig. 5 Basal lamina of smooth muscle cells in diabetic gastroparesis. (A–C)
The smooth muscle cells are normal featured but their basal lamina is
markedly thickened. (A and C), the basal lamina (arrows) around the
smooth muscle cells (SMC) is continuously thickened and in (B) patchily.
In (A), the stroma is particularly rich in collagen fibrils. Bar  0.5 m. In
(B), note elastic fibres (E) connecting nerve endings (NE), all of which have
a thick basal lamina and one (upper side) contains some synaptic vesicles.
Collagen fibrils (f). (A) is from patient #2, (B) from patient #6 and (C) from
patient #5. Bar  0.6 m.
Fig. 6 Nerve endings in diabetic gastroparesis. (A) A nerve bundle encased
in a fibrillar stroma. One of the nerve endings (asterisk) is very large and
empty (patient #2). SMC: smooth muscle cell. Bar  0.5 m. (B) Two
nerve endings (NE) filled with neurofilaments and attached to smooth mus-
cle cells (SMC) by elastic fibres (E, patient #10). Bar  0.5 m. (C) A small
intramuscular nerve bundle with four nerve endings. The nerve bundle is
surrounded by a very thick basal lamina and numerous collagen fibrils. The
nerve endings did not contain synaptic vesicles (patient #1). Bar  0.8 m.
(D) Free nerve endings (N) containing synaptic vesicles and one of which
is in close contact (arrow) with a smooth muscle cell (SMC, patient #2).
The stroma is rich in collagen fibrils. Bar  0.4 m.
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large vacuoles that filled the cytoplasm (Fig. 7B and C). As in
 diabetic gastroparesis, none of the ICC was in contact with nerve
endings and rarely with each other and the smooth muscle cells
(Fig. 7A). Also, ICC with apoptotic features similar to those seen in
diabetic gastroparetics were seen in all patients with idiopathic
 gastroparesis. Both, intramuscular ICC and ICC in the myenteric
plexus region had similar ultrastructural changes. The majority of
the smooth muscle cells were normal, gap junctions were always
present and some showed caveolae arranged in long rows 
(Fig. 8A). Only a few smooth muscle cells (again 2–3cells/section)
showed morphological alterations (Fig. 8B) and these findings
were similar to those observed in diabetic gastroparesis.
Nerve structures in all patients showed markedly altered mor-
phology (Fig. 9A–D). In neuronal cell bodies, mitochondria had
cristae with abnormal shape and orientation (Fig. 9A).
Neurofilaments were chaotically arranged (no more oriented par-
allel to each other and to the major axis of the axon and often
forming whorls) in both interganglial and intramuscular axons
(Fig. 9A and D). Some of the intramuscular nerve endings were
large and empty (Fig. 9C) and others contained lamellar bodies
and synaptic vesicles sequestered in membranous envelopes 
(Fig. 9B and C). Nerve bundles containing normal nerve endings
as well as free nerve endings were rarely seen. Glial cells
ensheathing axons were also altered, with cytoplasm filled with
lysosomes, and vacuoles (Fig. 9B–D).
The connective stroma showed fibrosis with a marked increase
in collagen fibrils, which were particularly abundant around the
nerve structures (Fig. 9C). Conversely, the basal lamina had a 
normal thickness everywhere which distinguished patients with
idiopathic gastroparesis from diabetic gastroparesis with the
exception of 2 patients (4 and 18) with a diagnosis of idiopathic
gastroparesis who had a thick basal lamina patchily distributed
around smooth muscle cells, ICC and nerve endings. Mast cells
were seen but less commonly than in diabetic gastroparesis.
Discussion
There are two main findings that emerge from this study. The first
is that TEM can identify cellular changes in all patients studied
with diabetic and idiopathic gastroparesis. Even in the patients
with no apparent immunohistological changes on light
microscopy, ultrastructural evidence for cellular damage was
present. TEM therefore offers an additional tool to study these
patients and can provide additional information over light
microscopy. The finding that 100% of patients with delayed gas-
tric emptying have cellular changes in the muscle wall of the stom-
ach suggests that these cellular changes may be responsible for
Fig. 7 Interstitial cells of Cajal abnormalities in idiopathic gastroparesis.
(A) An interstitial cell of Cajal (ICC) with apparently normal features in con-
tact (arrows) with normal featured smooth muscle cells (SMC, patient
#14). Bar  1 m. (B) A presumptive ICC (ICC) with clear mitochondria
and intracytoplasmatic lamellar bodies near nerve endings (N, patient #16).
SMC: smooth muscle cell with a large vacuole containing dense bodies.
Bar  1 m. (C) A presumptive ICC showing evidence of severe injury
(patient #1). The cytoplasm is dark and very large vacuoles (V) occupy
large portions of the cell. Bar  0.6 m.
Fig. 8 Smooth muscle cells changes in idiopathic gastroparesis. (A) Two
smooth muscle cells, one of which (SMC) has particularly numerous cave-
olae (asterisks) aligned all along the plasma membrane (patient #10). The
arrow indicates a gap junction between the two smooth muscle cells. Bar 
0.6 m. (B) A smooth muscle cell with swollen mitochondria, lipofuscinic
bodies (asterisk) and lamellar bodies (arrow, patient #10). Bar  0.6 m.
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the electrical and contractile abnormalities associated with gastro-
paresis. The second finding to emerge from this study is that there
are significant differences between the ultrastructural defects in
diabetic and idiopathic gastroparesis as highlighted in Table 2.
All tissues examined in this study had ICC, nerve or smooth mus-
cle cell changes suggestive of injury consistent with the diagnosis of
gastroparesis with documented delayed gastric emptying. These
abnormalities, however, had a different appearance between the two
disorders. Nineteen of 20 diabetic gastroparesis patients had a thick-
ened basal lamina around smooth muscle cells and nerves. In con-
trast, tissues from 18 of 20 patients with idiopathic gastroparesis did
not have the thickened basal lamina around smooth muscle cells and
nerves but had more intense fibrosis than those from diabetic gas-
troparesis. Nerve damage was much more prominent in idiopathic
gastroparesis with both nerve cell bodies and nerve fibres affected to
a greater degree. Unlike in diabetic gastroparesis, glial cells were also
abnormal in idiopathic gastroparesis.
Interstitial cells of Cajal were affected in both diabetic and idio-
pathic gastroparesis. Loss of ICC, already described in delayed
gastric emptying associated with diabetes in mice, rats and human
light microscopy studies [11, 13–19, 21], was confirmed and the
findings extended to idiopathic gastroparesis. Moreover, TEM
allowed the determination that residual ICC were rarely in contact
with each other and smooth muscle cells and never to nerve end-
ings. This is in sharp contrast to what is seen in control tissues.
Given the role ICC play in the control of gastric motility [25] we can
reasonably hypothesize that these findings will have a significant
impact on the coordinated motor activity in both types of disorders.
Transmission electron microscopy also confirmed previous
findings of abnormalities of nerve tissue in both disorders; the loss
and/or alterations of synaptic vesicles we presently observed are in
agreement with the loss of expression of several neurotransmitters
and the neuronal nitric oxide synthase, previously demonstrated
[14–16, 19] in diabetic and/ or idiopathic gastroparesis [11, 13, 14,
17, 21]. As outlined above, neuronal cell body, nerve fibres and
glial cells were markedly altered in idiopathic gastroparesis, while
only nerve ending abnormalities were seen in the diabetic patients.
Smooth muscle cell abnormalities were not commonly seen
in diabetic and idiopathic gastroparesis and gap junctions were
maintained in all patients studied. However, contractile activity of
the muscle coat may still be compromised because the smooth
Table 2 Differences in severity of various ultrastructural changes in
diabetic and idiopathic gastroparesis
Diabetic 
gastroparesis
Idiopathic 
gastroparesis
ICC
Ultrastructural damage  
a Poor ICC-ICC and ICC-smooth
muscle contacts
 
a Loss of ICC-nerve endings contacts  
a Apoptotic features  
Smooth muscle
a Altered morphology  
a Patchily and/or continuously 
thickened basal lamina
 
Nerves
a Altered neuronal bodies  
a Altered nerve endings  
a Thick connective sheath  
Connective tissue stroma
a Fibrosis (marked increase in
 collagen fibrils)
 
a Thickened basal lamina  
() indicates no abnormalities. (, , ) indicates increasing
severity of abnormality.
Fig. 9 Nerve cell bodies and endings in idiopathic gastroparesis. (A) A
myenteric ganglion with severely altered axons and neurons (patient #10).
Two axons (asterisks) are enlarged and contain chaotically arranged 
neurofilaments. The mitochondria of the neuron (N) had abnormal cristae.
Bar  0.6 m. (B) A small intramuscular nerve bundle immersed in a
stroma rich in collagen fibrils (patient #10). The nerve endings (A) contain
lamellar bodies and synaptic vesicles sequestered by a membranous enve-
lope. Arrow: a free nerve ending (N) containing synaptic vesicles. SMC:
smooth muscle cell; G: glial cell. Bar  0.6 m. (C) A small intramuscular
nerve bundle encased in a thick fibrillar sheath (patient #15). Nerve end-
ings (A) are empty or contain sequestered synaptic vesicles. G: glial cell. 
Bar  0.6 m. (D) A large nerve bundle with altered nerve endings. Some
axons are empty (asterisks) and others are filled with filaments (two 
asterisks, patient #6). G: glial cells. In (A–C), the cytoplasm of the glial cells
contains lamellar bodies. Bar  1 m.
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muscle cells were encased in a less elastic stroma. The TEM
findings of markedly increased thin, scattered collagen fibrils
that were not organized in bundles may explain why under light
microscopy fibrosis (presence of thick bundles of fibrils) was
rarely found [26]. The separation of nerves from ICC, and ICC
and nerves from smooth muscle seen on TEM in both disorders
suggests that there may be also impaired neurotransmission and
transmission of the ICC electrical signal to smooth muscle
affecting contractility. Furthermore, the marked changes in the
basal lamina seen in diabetic gastroparesis, with the basal lam-
ina either continuously or patchily thickened was similar to what
has been described in other organs affected by diabetes such as
blood vessels, the retina and the kidney. Its functional implica-
tion is a likely decreased ability to exchange metabolites leading
to cell damage.
Similarly, the fibrillar sheath observed in idiopathic gastropare-
sis around smooth muscle cells, ICC and nerves may also com-
promise smooth muscle cell metabolism and cause cell sufferance
(presence of vacuoles, lipofuscinic and lamellar bodies, disor-
dered arrangement of myofilaments).
In conclusion, in this large ultrastructural study of prospec-
tively collected tissue from both diabetic and idiopathic gastro-
paresis multiple cellular abnormalities were seen. TEM not only
confirmed the light microscopy findings but also allowed two new
observations to be made. All 40 patients with gastroparesis had
cellular abnormalities when the tissue is examined under TEM.
Also, while light microscopy does not differentiate well between
diabetic and idiopathic gastroparesis, TEM does. In particular, a
thick basal lamina was strongly associated with diabetic gastro-
paresis, while more severe damage to ICC and neurons was asso-
ciated with idiopathic gastroparesis. The known fairly rapid
turnover of ICC [25, 27, 28] and the sparing of synaptic vesicles
offer hope that diabetic gastroparesis may be reversible with ther-
apy. This is borne out by animal studies that have shown the
reversibility of the global cellular and neuromuscular or motility
changes [3, 4, 29, 30]. Conversely, in idiopathic gastroparesis, the
severe nerve tissue (neuronal cell bodies, nerve endings and glial
cells) impairment may play a larger role in development of gastro-
paresis. These insights should help differentiate the two disorders
and also provide direction for the development of therapy targeted
to each disorder.
Acknowledgements
We give thanks to Dr. Sean Harbison, Megan Garrity-Park, Shelly Gray,
Valerie McNair, Gary Stoltz, Peter Strege and Kristy Zodrow for excellent
technical and secretarial assistance, and to Daniele Guasti for his precious
and excellent technical support for the electron microscope study. The
Gastroparesis Clinical Research Consortium (GpCRC) is supported by the
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
(grants U01DK073983, U01DK073975, U01DK073985, U01DK074007,
U01DK073974, U01DK074008). This work was also supported by
DK57061, DK84567 and PO1 DK68055.
Conflict of interest
The authors confirm that there are no conflicts of interest.
Authors’ contributions
Henry Parkman, Thomas Abell, William Snape, Pankaj J. Pasricha,
Maria Simonetta Faussone-Pellegrini, Madhusudan Grover, Gianrico
Farrugia: acquisition of tissue and drafting of manuscript, critical
review of the manuscript for important intellectual content, study
concept and design, analysis and interpretation of data, critical revi-
sion of the data for important intellectual content, obtained funding.
Matthew Lurken, Cheryl Bernard, Thomas Smyrk: study concept
and design, analysis and interpretation of data, critical revision of
the data for important intellectual content.
William Hasler, Aynur Unalp-Arida, Linda Nguyen, Kenneth
Koch, Jorges Calles, Linda Lee, James Tonascia, Frank Hamilton:
analysis, interpretation of data, critical revision of the manuscript
for important intellectual content.
Members of the Gastroparesis Clinical
Research Consortium as of April 2011
Clinical Centers
Stanford University, Stanford, CA, USA: Pankaj Jay Pasricha, MD
(Principal Investigator); Linda Nguyen, MD; Nighat Ullah, MD
California Pacific Medical Center, San Francisco, CA, USA:
William Snape, MD (Principal Investigator); Robin Bishop (2008);
Nata DeVole, RN; Mary Greene, MS; Sue Louiseau; Amy Marincek,
RN, BSN (2008); Shelly Parker, RN MSN ANP-C ANP; Eve Pillor,
RN MSN FNP; Courtney Ponsetto, RN; Katerina Shetler, MD
Mayo Clinic College of Medicine, Rochester, MN, USA:
Gianrico Farrugia, MD (Principal Investigator); Madhusudan
Grover, MD; Cheryl Bernard; Matt Lurken (2007–2009); K. Robert
Shen, MD; Michael Sarr, MD; Michael Kendrick, MD
Temple University, Philadelphia, PA, USA: Henry P. Parkman,
MD (Principal Investigator); Siva Doma, MD (2006–2007); Javier
Gomez, MD (2008–2009); Steven Kantor; Vanessa Lytes, CRNP;
Amiya Palit, MD; Zeeshan Ramzan, MD (2007–2008); Priyanka
Sachdeva, MD; Kellie Simmons, RN; Sean Harbison, MD
Texas Tech University Health Sciences Center: Richard W.
McCallum, MD (Principal Investigator); Reza Hejazi, MD; Irene
Sarosiek, MD; Denise Vasquez; Natalia Vega
University of Michigan, Ann Arbor, MI, USA: William Hasler,
MD (Principal Investigator); Michelle Atkinson, CSC; Radoslav
Coleski, MD (2007–2008)
University of Mississippi Medical Center, Jackson, MS, USA:
Thomas Abell, MD (Principal Investigator); JoAnne Fordham; Olivia
Henry, RD; Archana Kedar, MD; Valerie McNair, LPN II; Susanne
Pruett, RN (2007–2008); Margaret Smith, RN; Danielle Spree, CNP
J. Cell. Mol. Med. Vol 16, No 7, 2012
1581© 2011 The Authors
Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Wake Forest University, Winston-Salem, NC, USA: Kenneth
Koch, MD (Principal Investigator); Lynn Baxter; Jorge Calles, MD;
Samantha Culler; Judy Hooker, RN; Paula Stuart, PA
Resource Centers
National Institute of Diabetes, Digestive and Kidney Diseases,
Bethesda, MD, USA: Frank Hamilton, MD, MPH (Project Scientist);
Steven James, MD; Rebecca Torrance, RN, MSN; Rebekah Van
Raaphorst, MPH
Johns Hopkins University, Bloomberg School of Public
Health (Data Coordinating Center), Baltimore, MD, USA: James
Tonascia, PhD (Principal Investigator); Patricia Belt; Ryan Colvin,
MPH; Michele Donithan, MHS; Mika Green, MA; Milana
Isaacson; Wana Kim; Linda Lee, MD; Alison Lydecker, MPH
(2006–2008); Pamela Mann, MPH (2008–2009); Laura Miriel;
Alice Sternberg, ScM; Aynur Ünalp-Arida, MD, PhD; Mark Van
Natta, MHS; Ivana Vaughn, MPH; Laura Wilson, ScM; Katherine
Yates, ScM
References
1. Farrell FJ, Keeffe EB. Diabetic gastro-
paresis. Dig Dis. 1995; 13: 291–300.
2. Stanciu GO. Gastroparesis and its man-
agement. Rev Med Chir Soc Med Nat Iasi.
2001; 105: 451–6.
3. Choi KM, Gibbons SJ, Nguyen TV, et al.
Heme oxygenase-1 protects interstitial cells
of Cajal from oxidative stress and reverses
diabetic gastroparesis. Gastroenterology.
2008; 135: 2055–64, 2064 e1–2.
4. Horvath VJ, Vittal H, Lorincz A, et al.
Reduced stem cell factor links smooth
myopathy and loss of interstitial cells of
Cajal in murine diabetic gastroparesis.
Gastroenterology. 2006; 130: 759–70.
5. Ordog T, Takayama I,  Cheung WK, et al.
Remodeling of networks of interstitial cells
of Cajal in a murine model of diabetic gas-
troparesis. Diabetes. 2000; 49: 1731–9.
6. Spangeus A,  El-Salhy M. Myenteric
plexus of obese diabetic mice (an animal
model of human type 2 diabetes). Histol
Histopathol. 2001; 16: 159–65.
7. Spangeus A, Suhr O, El-Salhy M. Diabetic
state affects the innervation of gut in an
animal model of human type 1 diabetes.
Histol Histopathol. 2000; 15: 739–44.
8. Takahashi T, Nakamura K, Itoh H, et al.
Impaired expression of nitric oxide synthase
in the gastric myenteric plexus of sponta-
neously diabetic rats. Gastroenterology.
1997; 113: 1535–44.
9. Vittal H, Farrugia G, Gomez G, et al.
Mechanisms of disease: the pathological
basis of gastroparesis–a review of experi-
mental and clinical studies. Nat Clin Pract
Gastroenterol Hepatol. 2007; 4: 336–46.
10. Wang XY, Huizinga JD, Diamond J, et al.
Loss of intramuscular and submuscular
interstitial cells of Cajal and associated
enteric nerves is related to decreased gas-
tric emptying in streptozotocin-induced
diabetes. Neurogastroenterol Motil. 2009;
21: 1095–e92.
11. Battaglia E, Bassotti G, Bellone G, et al.
Loss of interstitial cells of Cajal network in
severe idiopathic gastroparesis. World J
Gastroenterol. 2006; 12: 6172–7.
12. Ejskjaer NT, Bradley JL, Buxton-Thomas
MS, et al. Novel surgical treatment and
gastric pathology in diabetic gastroparesis.
Diabet Med. 1999; 16: 488–95.
13. Forster J, Damjanov I,  Lin Z, et al.
Absence of the interstitial cells of Cajal in
patients with gastroparesis and correlation
with clinical findings. J Gastrointest Surg.
2005; 9: 102–8.
14. Harberson J, Thomas RM, Harbison SP,
et al. Gastric neuromuscular pathology in
gastroparesis: analysis of full-thickness
antral biopsies. Dig Dis Sci. 2010; 55:
359–70.
15. He CL, Soffer EE, Ferris CD, et al. Loss of
interstitial cells of Cajal and inhibitory
innervation in insulin-dependent diabetes.
Gastroenterology. 2001; 121: 427–34.
16. Iwasaki H, Kajimura M, Osawa S, et al.
A deficiency of gastric interstitial cells of Cajal
accompanied by decreased expression of
neuronal nitric oxide synthase and substance
P in patients with type 2 diabetes mellitus. 
J Gastroenterol. 2006; 41: 1076–87.
17. Lin Z,  Sarosiek I,  Forster J,  et al.
Association of the status of interstitial cells
of Cajal and electrogastrogram parameters,
gastric emptying and symptoms in patients
with gastroparesis. Neurogastroenterol
Motil. 2010; 22: 56–61, e10.
18. Miller SM, Narasimhan RA, Schmalz PF,
et al. Distribution of interstitial cells of Cajal
and nitrergic neurons in normal and dia-
betic human appendix. Neurogastroenterol
Motil. 2008; 20: 349–57.
19. Pasricha PJ, Pehlivanov ND, Gomez G, 
et al. Changes in the gastric enteric 
nervous system and muscle: a case report
on two patients with diabetic gastroparesis.
BMC Gastroenterol. 2008; 8: 21.
20. Sokol H, Lavergne-Slove A, Mikol J,  
et al. Severe isolated myopathic gastro-
paresis: a case report with pathological
findings. Gut. 2006; 55: 1662.
21. Zarate N, Mearin F, Wang XY, et al.
Severe idiopathic gastroparesis due to
neuronal and interstitial cells of Cajal
degeneration: pathological findings and
management. Gut. 2003; 52: 966–70.
22. Grover M, Farrugia G, Lurken MS, et al.
Cellular changes in diabetic and idiopathic
gastroparesis. Gastroenterology. 2011;
140: 1575–85 e8.
23. Faussone-Pellegrini MS, Pantalone D,
Cortesini C. An ultrastructural study of the
smooth muscle cells and nerve endings of
the human stomach. J Submicrosc Cytol
Pathol. 1989; 21: 421–37.
24. Faussone-Pellegrini MS, Pantalone D,
Cortesini C. An ultrastructural study of the
interstitial cells of Cajal of the human
stomach. J Submicrosc Cytol Pathol.
1989; 21: 439–60.
25. Farrugia G. Interstitial cells of Cajal in
health and disease. Neurogastroenterol
Motil. 2008; 20 Suppl 1: 54–63.
26. Yoshida MM, Schuffler MD, Sumi SM.
There are no morphologic abnormalities of
the gastric wall or abdominal vagus in
patients with diabetic gastroparesis.
Gastroenterology. 1988; 94: 907–14.
27. Gibbons SJ, De Giorgio R, Pellegrini MS,
et al. Apoptotic cell death of human inter-
stitial cells of Cajal. Neurogastroenterol
Motil. 2009; 21: 85–93.
28. Tharayil VS, Wouters MM, Stanich JE, et al.
Lack of serotonin 5-HT2B receptor alters
proliferation and network volume of intersti-
tial cells of Cajal in vivo. Neurogastroenterol
Motil. 2010; 22: 462–9, e109–10.
29. Choi KM, Kashyap PC, Dutta N, et al. CD206-
positive M2 macrophages that express
heme oxygenase-1 protect against diabetic
gastroparesis in mice. Gastroenterology.
2010; 138: 2399–409, 2409 e1.
30. Watkins CC, Sawa A, Jaffrey S, et al.
Insulin restores neuronal nitric oxide syn-
thase expression and function that is lost
in diabetic gastropathy. J Clin Invest. 2000;
106: 373–84.
